Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Calvis-C is a combination nutritional supplement manufactured by Davis Pharma, primarily containing calcium (typically in the form of calcium carbonate) and ascorbic acid (Vitamin C). It is marketed as a branded generic product in Pakistan, categorized within the company's vitamins and nutraceutical portfolio. The supplement is designed to prevent and treat calcium deficiency and support bone density, particularly in conditions such as osteoporosis, osteomalacia, and rickets. The addition of Vitamin C serves to enhance the absorption of calcium and provide antioxidant support for immune health and collagen synthesis. It is generally available in oral dosage forms, such as tablets or effervescent tablets.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on calcium carbonate + ascorbic acid.